Showing results (61-70 of 342) with videos related to
Sort By:
Pageof 35
Oncotarget|March 2, 2016
Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cellsDaniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, et al.Cancers|December 10, 2021
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective StudyUros Markovic, Alessandra Romano, Claudia Bellofiore, et al.Hematological Oncology|December 23, 2011
Endoscopic ultrasonography in gastric lymphomas: appraisal on reliability in long-term follow-upCalogero Vetro, Alessandra Romano, Annalisa Chiarenza, et al.Cancers|April 14, 2025
Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple MyelomaKatia Mancuso, Simona Barbato, Francesco Di Raimondo, et al.Haematologica|May 5, 2022
Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort studyGaetano Giuffrida, Uros Markovic, Annalisa Condorelli, et al.Cancer|December 11, 2012
External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemiaStefano Molica, Diana Giannarelli, Massimo Gentile, et al.Frontiers in Pharmacology|April 8, 2026
Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIsMichele Massimino, Elena Tirrò, Chiara Romano, et al.Skeletal Radiology|March 2, 2011
Vertebroplasty in multiple myeloma with osteolysis or fracture of the posterior vertebral wall. Usefulness of a delayed cement injectionAntonio Basile, Maide Cavalli, Paolo Fiumara, et al.Leukemia Research|March 19, 2013
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysisStefano Molica, Diana Giannarelli, Massimo Gentile, et al.Journal of Clinical Medicine|March 29, 2023
Myelofibrosis and Survival Prognostic Models: A Journey between Past and FutureAndrea Duminuco, Antonella Nardo, Gaetano Giuffrida, et al.Pageof 35